Cardiac Manifestations of Systemic Lupus Erythematosus

被引：114

作者：

Miner, Jonathan J. ^{[1
]}

Kim, Alfred H. J. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2014年 / 40卷 / 01期

关键词：

Systemic lupus erythematosus; Neonatal lupus; Congenital heart block; Myocarditis; Pericarditis; Coronary artery disease; Libman-Sacks; CONGENITAL HEART-BLOCK; CONNECTIVE-TISSUE DISEASE; LIBMAN-SACKS ENDOCARDITIS; AORTIC-VALVE-REPLACEMENT; ANTI-RO/SSA ANTIBODIES; CORRECTED QT INTERVAL; NEONATAL LUPUS; RISK-FACTORS; CONSTRICTIVE PERICARDITIS; ANTIPHOSPHOLIPID SYNDROME;

D O I：

10.1016/j.rdc.2013.10.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that manifests with multiorgan inflammation. Cardiac involvement is common, with manifestation that include pericarditis, myocarditis, conduction defects, valvular disease, and coronary artery disease. In addition to cardiac disease in adults with SLE, the children of women with SLE can develop neonatal lupus by passive transfer of autoantibodies across the placenta. This article describes the cardiac manifestations of SLE and highlights some key unanswered questions about the disease and its pathogenesis.

引用

页码：51 / +

页数：12

共 75 条

[1]

ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259

[2] Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus [J].

Anania, Cristina ;

Gustafsson, Thomas ;

Hua, Xiang ;

Su, Jun ;

Vikstrom, Max ;

de Faire, Ulf ;

Heimburger, Mikael ;

Jogestrand, Tomas ;

Frostegard, Johan .

ARTHRITIS RESEARCH & THERAPY, 2010, 12 (06)

[3] Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort [J].

Apte, M. ;

McGwin, G., Jr. ;

Vila, L. M. ;

Kaslow, R. A. ;

Alarcon, G. S. ;

Reveille, J. D. .

RHEUMATOLOGY, 2008, 47 (03) :362-367

[4]

Arabi MT, 2012, BMJ CASE REP

[5] Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review [J].

Artenjak, Andrej ;

Lakota, Katja ;

Frank, Mojca ;

Cucnik, Sasa ;

Rozman, Blaz ;

Bozic, Borut ;

Shoenfeld, Yehuda ;

Sodin-Semrl, Snezna .

AUTOIMMUNITY REVIEWS, 2012, 11 (12) :873-882

[6] Aortic Valve Replacement in the Elderly Determinants of Late Outcome [J].

Ashikhmina, Elena A. ;

Schaff, Hartzell V. ;

Dearani, Joseph A. ;

Sundt, Thoralf M., III ;

Suri, Rakesh M. ;

Park, Soon J. ;

Burkhart, Harold M. ;

Li, Zhuo ;

Daly, Richard C. .

CIRCULATION, 2011, 124 (09) :1070-U183

[7] Transcatheter aortic valve replacement for advanced valvular disease in active SLE and APS [J].

Bert, J. S. ;

Abdullah, M. ;

Dahle, T. G. ;

Gertner, E. .

LUPUS, 2013, 22 (10) :1046-1049

[8] CORONARY ARTERITIS, OCCLUSION, AND MYOCARDIAL-INFARCTION DUE TO LUPUS-ERYTHEMATOSUS [J].

BONFIGLIO, TA ;

BOTTI, RE ;

HAGSTROM, JW .

AMERICAN HEART JOURNAL, 1972, 83 (02) :153-+

[9] Prolonged Corrected QT Interval in Anti-Ro/SSA-Positive Adults With Systemic Lupus Erythematosus [J].

Bourre-Tessier, Josiane ;

Clarke, Ann E. ;

Thao Huynh ;

Bernatsky, Sasha ;

Joseph, Lawrence ;

Belisle, Patrick ;

Pineau, Christian A. .

ARTHRITIS CARE & RESEARCH, 2011, 63 (07) :1031-1037

[10]

Boyle JJ, 1997, J PATHOL, V181, P93, DOI 10.1002/(SICI)1096-9896(199701)181:1<93::AID-PATH696>3.0.CO

← 1 2 3 4 5 6 7 8 →